Hoffman ALS Clinical Trial Awards
Funds clinical trial development for ALS interventions in early development phases.
The Hoffman ALS Clinical Trial Awards Program is an annual initiative of The ALS Association, the largest philanthropic funder of ALS research in the world, which has committed over $162 million to nearly 600 projects since 2014. The program de-risks early-stage clinical development by providing up to $1,000,000 in total funding over two or three years to support phase 1 or phase 2a biomarker-driv…
Phase 1 or 2a biomarker-driven clinical trials of novel or repurposed therapeutics for ALS, including disease-modifying, symptomatic, and imaging-tracer approaches. Particular interest in TDP-43 and protein aggregation programs.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see what winners did
Sign up free to see where teams trip up